Post-Hoc Analysis of a Head-to-Head Hyaluronic Acid Comparison in Knee Osteoarthritis Using the 2004 OMERACT-OARSI Responder Criteria

Erol Onel; Kathleen Kolsun; Jeffrey I. Kauffman

Medicine
Published in Clinical drug investigation 2008
DOI:10.2165/00044011-200828010-00005

Post-Hoc Analysis of a Head-to-Head Hyaluronic Acid Comparison in Knee Osteoarthritis Using the 2004 OMERACT-OARSI Responder Criteria

@article{Onel2008PostHocAO,
  title={Post-Hoc Analysis of a Head-to-Head Hyaluronic Acid Comparison in Knee Osteoarthritis Using the 2004 OMERACT-OARSI Responder Criteria},
  author={Erol Onel and Kathleen Kolsun and Jeffrey I. Kauffman},
  journal={Clinical Drug Investigation},
  year={2008},
  volume={28},
  pages={37-45}
}

Erol Onel, Kathleen Kolsun, Jeffrey I. Kauffman

Background and objective:Several intra-articular hyaluronic acid products are available for treating osteoarthritis (OA) of the knee, including hylan G-F 20 and the bioengineered straight-chain hyaluronic acid (Bio-HA). A recently published study in patients with knee OA demonstrated non-inferiority with regard to efficacy, using the pain subscore of the Western Ontario and McMaster Universities Osteoarthritis Index (safety data favoured Bio-HA with regard to knee effusions). However, the… CONTINUE READING

View on Springer